Temporal pattern of NFκB activation influences apoptotic cell fate in a stimuli-dependent fashion

Journal of Cell Science

Volumn 115, Issue 24, 2002, Pages 4843-4853

  Fan, Chenguang ^a   Yang, Jusan ^a   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antisense inhibition; Apoptosis; NF B activation; Signal transduction

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PERVANADATE; SERINE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PRIMER DNA; VANADIC ACID;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL FATE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REOXYGENATION; REPERFUSION; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION; CELL LINEAGE; DRUG EFFECT; HELA CELL; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

ADENOVIRIDAE;

APOPTOSIS; BASE SEQUENCE; CELL LINEAGE; DNA PRIMERS; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PHOSPHORYLATION; RNA, ANTISENSE; SERINE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; ULTRAVIOLET RAYS; VANADATES;

EID: 0037115616     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00151     Document Type: Article

References (35)

1. Abu-Amer, Y., Ross, F. P., McHugh, K. P., Livolsi, A., Peyron, J. F. and Teitelbaum, S. L. (1998). Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. J. Biol. Chem. 273, 29417-29423.
2. Andrews, N. C. and Faller, D. V. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499.
3. Baichwal, V. R. and Baeuerle, P. A. (1997). Activate NF-kappa B or die? Curr. Biol. 7, R94-R96.
4. Bender, K., Gottlicher, M., Whiteside, S., Rahmsdorf, H. J. and Herrlich, P. (1998). Sequential DNA damage-independent and -dependent activation of NF- kappaB by UV. EMBO J. 17, 5170-5181.
5. Beraud, C., Henzel, W. J. and Baeuerle, P. A. (1999). Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc. Natl. Acad. Sci. USA 96, 429-434.
6. Bui, N. T., Livolsi, A., Peyron, J. F. and Prehn, J. H. (2001). Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J. Cell Biol. 152, 753-764.
7. Davis, A. R. and Wilson, J. M. (1996). Adenoviral Vectors. In Current protocols in human genetics, vol. 3 (eds N. C. Dracopoli, J. L. Haines, B. R. Korf, C. C. Morton, C. E. Seidman, J. G. Seidman, D. R. Smith and D. T. Moir), pp. 12.4.1-12.4.18. John Wiley & Sons. Inc.
8. Fan, C., Zwacka, R. M. and Engelhardt, J. F. (1999). Therapeutic approaches for ischemia/reperfusion injury in the liver. J. Mol. Med. 77, 577-592.
9. Grilli, M., Pizzi, M., Memo, M. and Spano, P. (1996). Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274, 1383-1385.
10. Grimm, S., Bauer, M. K., Baeuerle, P. A. and Schulze-Osthoff, K. (1996). Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 134, 13-23.
11. Hirano, M., Osada, S., Aoki, T., Hirai, S., Hosaka, M., Inoue, J. and Ohno, S. (1996). MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha. J. Biol. Chem. 271, 13234-13238.
12. Iimuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K. E., Schoonhoven, R., Grisham, J. W. and Brenner, D. A. (1998). NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811.
13. Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A. et al. (1996). Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86, 787-798.
14. Jobin, C. and Sartor, R. B. (2000). The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol. 278, C451-C462.
15. Karin, M. and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-663.
16. Kulms, D., Poppelmann, B. and Schwarz, T. (2000). Ultraviolet radiation-induced interleukin 6 release in HeLa cells is mediated via membrane events in a DNA damage-independent way. J. Biol. Chem. 275, 15060-15066.
17. Lamberti, C., Lin, K. M., Yamamoto, Y., Verma, U., Verma, I. M., Byers, S. and Gaynor, R. B. (2001). Regulation of beta-catenin function by the IkappaB kinases. J. Biol. Chem. 276, 42276-42286.
18. Lawrence, T., Gilroy, D. W., Colville-Nash, P. R. and Willoughby, D. A. (2001). Possible new role for N-F-kappaB in the resolution of inflammation. Nat. Med 7, 1291-1297.
19. Lee, F. S., Hagler, J., Chen, Z. J. and Maniatis, T. (1997). Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222.
20. Li, N. and Karin, M. (1998). Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95, 13012-13017.
21. Li, Q., Sanlioglu, S., Li, S., Ritchie, T., Oberley, L. and Engelhardt, J. F. (2001). GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxid. Redox Signal. 3, 415-432.
22. Lipton, S. A. (1997). Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat. Med. 3, 20-22.
23. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87, 565-576.
24. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin, A. S., Jr and Mayo, M. W. (2000). Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20, 1626-1638.
25. Morgan, E. N., Boyle, E. M., Jr, Yun, W., Griscavage-Ennis, J. M., Farr, A. L., Canty, T. G., Jr, Pohlman, T. H. and Verrier, E. D. (1999). An essential role for NF-kappaB in the cardioadaptive response to ischemia. Ann. Thorac. Surg. 68, 377-382.
26. Piette, J., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M. P., Legrand-Poels, S. and Bours, V. (1997). Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem. 378, 1237-1245.
27. Rudolph, D., Yeh, W. C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J. and Mak, T. W. (2000). Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14, 854-862.
28. Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B., Jr, Ritchie, T. C., Hunninghake, G. W., Zandi, E. and Engelhardt, J. F. (2001). Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J. Biol. Chem. 276, 30188-30198.
29. Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T. and Ballard, D. W. (1995). Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92, 11259-11263.
30. Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L. and Goeddel, D. V. (1999). Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10, 421-429.
31. Tojima, Y., Fujimoto, A., Delhase, M., Chen, Y., Hatakeyama, S., Nakayama, K., Kaneko, Y., Nimura, Y., Motoyama, N., Ikeda, K. et al. (2000). NAK is an IkappaB kinase-activating kinase. Nature 404, 778-782.
32. Wang, C. Y., Mayo, M. W. and Baldwin, A. S., Jr (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
33. Yamamoto, Y. and Gaynor, R. B. (2001). Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135-142.
34. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. and Karin, M. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243-252.
35. Zwacka, R. M., Zhang, Y., Zhou, W., Halldorson, J. and Engelhardt, J. F. (1998). Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 28, 1022-1030.